93196-4
Warfarin response genotype panel - Blood or Tissue by Molecular genetics method
Active
46724-1 CYP2C9 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Term Description
The patient's allelic genotype (e.g. *1/*8) for the CYP2C9 gene allele. Testing may include the most common alleles of CYP2C9, such as *2, *6,*8,*11,*13,*15. The example answers provided with this code are a small representative of the CYP2C9 allelic genotypes. For a complete list of CYP2C9 alleles, see the The Human Cytochrome P450 (CYP) Allele Nomenclature Database (http://www.cypalleles.ki.se).
Source: Regenstrief LOINC
Part Descriptions
LP417568-5 CYP2C9 gene allele
Cytochrome P450-2C9 (CYP2C9; [HGNC Gene ID: 2623]), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism 10-15% of drugs in current clinical use. Genetic variations in CYP2C9 can affect the response (i.e., efficacy or toxicity) to drugs metabolized by CYP2C9 and selection of alternative dosing or agents may be necessary in individuals with specific CYP2C9 genetic variations. PMID: 25099164 PMID: 21900891 See https://www.pharmgkb.org/gene/PA126 for more information and dosing guidelines for drugs impacted by CYP2C9 genetic variation.
Source: Clinical Pharmacogenetics Implementation Consortium
Fully-Specified Name
- Component
- CYP2C9 gene allele
- Property
- Geno
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Nom
- Method
- Molgen
Additional Names
- Short Name
- CYP2C9 allele Geno Bld/T
- Display Name
- CYP2C9 gene allele genotype Molgen (Bld/Tiss)
- Consumer Name Alpha Get Info
- CYP2C9 gene allele genotype, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.19
- Last Updated
- Version 2.73
- Change Reason
- Release 2.68: CLASS: Updated to MOLPATH.PHARMG, the more representative LOINC Class for this concept.; COMPONENT: Updated Component to align with the LOINC term naming model for concepts used to report allelic genotypes (e.g. CYP2C9*1/*8), which was the original intent for this term.; Release 2.67: CLASS: Updated to MOLPATH.PHARMG, the more representative LOINC Class for this concept.; Previous Releases: Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 9570
Example Answer List LL5510-4
Answer | Code | Score | Answer ID |
---|---|---|---|
CYP2C9 *1/*2 | LA30670-6 | ||
CYP2C9 *1/*6 | LA30671-4 | ||
CYP2C9 *6/*11 | LA30672-2 |
Member of these Panels
LOINC | Long Common Name |
---|---|
54450-2 | CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method |
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: CYP2C9 Genotyp. |
es-ES | Spanish (Spain) | Alelo del gen CYP2C9: |
es-MX | Spanish (Mexico) | Alelo del gen CYP2C9: |
fr-FR | French (France) | CYP2C9 gène allèle: |
it-IT | Italian (Italy) | CYP2C9, gene allele: Synonyms: Farmacogenomica Gene CYP2C9 Genetica molecolare Genotipo Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
nl-NL | Dutch (Netherlands) | CYP2C9-allel: Synonyms: CYP2C9 gen molgen |
pt-BR | Portuguese (Brazil) | CYP2C9 análise de mutação genética: Synonyms: Cytochrome P450 2C9 Genotyping; |
zh-CN | Chinese (China) | CYP2C9 基因等位基因: Synonyms: CPC9; |
79716-7 CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Term Description
The CYP2C9 gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting CYP2C9 gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html]
Source: Regenstrief LOINC
Part Descriptions
LP202920-7 CYP2C9 gene product metabolic activity interpretation
Cytochrome P450-2C9 (CYP2C9; [HGNC Gene ID: 2623]), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism 10-15% of drugs in current clinical use. Genetic variations in CYP2C9 can affect the response (i.e., efficacy or toxicity) to drugs metabolized by CYP2C9 and selection of alternative dosing or agents may be necessary in individuals with specific CYP2C9 genetic variations. PMID: 25099164 PMID: 21900891 See https://www.pharmgkb.org/gene/PA126 for more information and dosing guidelines for drugs impacted by CYP2C9 genetic variation.
Source: Clinical Pharmacogenetics Implementation Consortium
Fully-Specified Name
- Component
- CYP2C9 gene product metabolic activity interpretation
- Property
- Imp
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Ord
- Method
- Molgen
Additional Names
- Short Name
- CYP2C9 gene prod met act imp Bld/T-Imp
- Display Name
- CYP2C9 gene product metabolic activity interpretation Molgen Ql (Bld/Tiss) [Interp]
- Consumer Name Alpha Get Info
- CYP2C9 gene product metabolic activity interpretation, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.54
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 14021
Preferred Answer List LL3856-3
Answer | Code | Score | Answer ID |
---|---|---|---|
Ultrarapid metabolizer | LA10315-2 | ||
Rapid metabolizer | LA25390-8 | ||
Normal metabolizer | LA25391-6 | ||
Intermediate metabolizer | LA10317-8 | ||
Poor metabolizer | LA9657-3 |
Member of these Panels
LOINC | Long Common Name |
---|---|
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen CYP2C9 interpretation de la actividad en el metabolismo de fármacos: |
es-MX | Spanish (Mexico) | Interpretación de la actividad metabólica del producto del gen CYP2C9: |
fr-FR | French (France) | CYP2C9 gène activité métabolique interprétation: |
it-IT | Italian (Italy) | Interpretazione dell'attività metabolica del gene CYP2C9: Synonyms: Farmacogenomica Gene CYP2C9 Genetica molecolare Impressione/interpretazione di studio Interpretazione dell''attività metabolica del gene Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
nl-NL | Dutch (Netherlands) | CYP2C9-gen product metabole activiteit interpretatie: Synonyms: CYP2C9 gen CYP2C9 gen product metabole activiteit interpretatie molgen |
tr-TR | Turkish (Turkey) | CYP2C9 geni ürünü metabolik aktivite yorumu: |
zh-CN | Chinese (China) | CYP2C9 基因产物新陈代谢活性解释: Synonyms: CPC9; |
50722-8 VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Term Description
The presence of the heterozygous missense mutation -1639 G>A in the VKORC1 gene can result in warfarin resistance. VKORC1 DNA analysis is performed by PCR followed by restriction enzyme digestion to detect -1639 G>A.
Source: Regenstrief LOINC
Part Descriptions
LP65679-0 VKORC1 gene
The VKORC1 gene (vitamin K epoxide reductase complex, subunit 1) [HGNC Gene ID:23663] is located on chromosome 16p11.2. Vitamin K is essential for blood clotting but must be enzymatically activated. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. The product of this gene encodes the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is the product of this gene that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance. Two pseudogenes have been identified on chromosome 1 and the X chromosome. Two alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008] [NCBI Gene ID:79001]
Source: National Center for Biotechnology Information (NCBI) Gene
Fully-Specified Name
- Component
- VKORC1 gene targeted mutation analysis
- Property
- Prid
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Nom
- Method
- Molgen
Additional Names
- Short Name
- VKORC1 gene Mut Anl Bld/T
- Display Name
- VKORC1 gene targeted mutation analysis Molgen Nom (Bld/Tiss)
- Consumer Name Alpha Get Info
- VKORC1 gene targeted mutation analysis, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.22
- Last Updated
- Version 2.73
- Change Reason
- Release 2.67: CLASS: Updated to MOLPATH.PHARMG, the more representative LOINC Class for this concept.; Previous Releases: Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 13213
Member of these Panels
LOINC | Long Common Name |
---|---|
54450-2 | CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method |
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: VKORC1 Genotyp. |
es-ES | Spanish (Spain) | Gen VKORC1 Analisis de mutaciones: |
es-MX | Spanish (Mexico) | Análisis de mutaciones dirigidas al gen VKORC1: |
fr-FR | French (France) | VKORC1 gène mutation cible trouvée: |
it-IT | Italian (Italy) | VKORC1, gene analisi di mutazione mirata: Synonyms: Farmacogenomica Gene VKORC1 Genetica molecolare Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
nl-NL | Dutch (Netherlands) | VKORC1-gen doelgerichte mutatie-analyse: Synonyms: molgen targeted VKORC1 gen |
pt-BR | Portuguese (Brazil) | VKORC1 análise de mutação genética: Synonyms: Vitamin K epoxide reductase complex, subunit 1; |
ru-RU | Russian (Russian Federation) | VKORC1 ген исследование на мутацию: Synonyms: Кровь Кровь или Ткань Номинальный; |
tr-TR | Turkish (Turkey) | VKORC1 geni Mutasyon analizi: |
zh-CN | Chinese (China) | VKORC1 基因 突变分析: Synonyms: VKCFD2; |
72507-7 VKORC1 gene c.1173C>T [Presence] in Blood or Tissue by Molecular genetics method
Term Description
The 1173C>T (rs9934438) is a single nucleotide polymorphism (SNP) within the VKORC1 gene associated with an increased risk of aortic calcification PMID: 18218987 and warfarin (coumarin) sensitivity PMID: 19955245.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- VKORC1 gene.c.1173C>T
- Property
- PrThr
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Ord
- Method
- Molgen
Additional Names
- Short Name
- VKORC1 c.1173C>T Bld/T Ql
- Display Name
- VKORC1 gene c.1173C>T Molgen Ql (Bld/Tiss)
- Consumer Name Alpha Get Info
- VKORC1 gene c.1173C>T, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.67
- Change Reason
- Release 2.67: CLASS: Updated to MOLPATH.PHARMG, the more representative LOINC Class for this concept.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
Example Answer List LL2014-0
Answer | Code | Score | Answer ID |
---|---|---|---|
Wild type | LA9658-1 | ||
Heterozygous | LA6706-1 | ||
Homozygous | LA6705-3 |
Member of these Panels
LOINC | Long Common Name |
---|---|
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen VKORC1 c.1173C>T: |
es-MX | Spanish (Mexico) | Gen VKORC1 c.1173C> T: |
fr-FR | French (France) | VKORC1 gène mutation c.1173C>T: |
it-IT | Italian (Italy) | VKORC1, gene.c.1173C>T: Synonyms: Farmacogenomica Gene VKORC1 Gene VKORC1 c.1173C> |
nl-NL | Dutch (Netherlands) | VKORC1-gen.c.1173C>T: Synonyms: molgen VKORC1 gen |
pt-BR | Portuguese (Brazil) | VKORC1 gene.c.1173C>T: |
ru-RU | Russian (Russian Federation) | VKORC1 ген.c.1173C>T: Synonyms: Кровь Кровь или Ткань Порядковый Ткань и мазки Точка во времени; |
tr-TR | Turkish (Turkey) | VKORC1 geni.c.1173C>T: Synonyms: Mevcut |
zh-CN | Chinese (China) | VKORC1 基因.c.1173C>T: Synonyms: C 型; |
93198-0 10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Term Description
The non-coding variant g.94645745G>A (rs12777823) located in the CYP2C cluster near the CYP2C18 gene on chromosome 10 is associated with warfarin dosing among African Americans (mainly originating from West Africa). For those with rs12777823 A/G or A/A genotypes, a warfarin dose reduction of 10-25% is recommended. PMID: 28198005
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- 10q23 g.94645745G>A
- Property
- Geno
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Nom
- Method
- Molgen
Additional Names
- Short Name
- 10q23 g.94645745G>A Geno Bld/T
- Display Name
- 10q23 g.94645745G>A genotype Molgen (Bld/Tiss)
- Consumer Name Alpha Get Info
- 10q23 g.94645745G>A genotype, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.67
- Last Updated
- Version 2.68
- Order vs. Observation
- Observation
Preferred Answer List LL2478-7
Answer | Code | Score | Answer ID |
---|---|---|---|
G/G (wild type) | LA19932-5 | ||
G/A (heterozygous) | LA19933-3 | ||
A/A (homozygous) | LA19934-1 |
Member of these Panels
LOINC | Long Common Name |
---|---|
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | 10q23 g.94645745G> A: |
es-ES | Spanish (Spain) | 10q23 g.94645745G> A: |
fr-FR | French (France) | 10q23 mutation g.94645745G>A: |
it-IT | Italian (Italy) | 10q23 g.94645745G>A: Synonyms: Farmacogenomica Genetica molecolare Genotipo Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
zh-CN | Chinese (China) | 10q23 g.94645745G>A: Synonyms: A 型 G 型 全血或组织; |
93197-2 CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Term Description
The presence of the CYP4F2*3 (rs2108622) allele indicates that a patient who self-identifies as being of non-African ancestry may require a slightly increased warfarin dose than predicted by CYP2C9/VKORC1 alone. PMID: 18250228 The rs2108622 variant (c.1297G>A) results in an amino acid substitution (valine to methionine) at position 433 (p.V433M).
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- CYP4F2 gene.c.1297G>A
- Property
- Geno
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Nom
- Method
- Molgen
Additional Names
- Short Name
- CYP4F2 c.1297G>A Geno Bld/T
- Display Name
- CYP4F2 gene c.1297G>A genotype Molgen (Bld/Tiss)
- Consumer Name Alpha Get Info
- CYP4F2 gene c.1297G>A genotype, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.67
- Last Updated
- Version 2.68
- Order vs. Observation
- Observation
Example Answer List LL5373-7
Answer | Code | Score | Answer ID |
---|---|---|---|
CYP4F2 *1/*1 | LA30244-0 | ||
CYP4F2 *1/*3 | LA30245-7 | ||
CYP4F2 *3/*3 | LA30246-5 |
Member of these Panels
LOINC | Long Common Name |
---|---|
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen CYP4F2 c.1297G> A: |
es-MX | Spanish (Mexico) | Gen CYP4F2 c.1297G> A: |
fr-FR | French (France) | CYP4F2 gène mutation c.1297G>A: |
it-IT | Italian (Italy) | CYP4F2 gene.c.1297G>A: Synonyms: Farmacogenomica Genetica molecolare Genotipo Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
zh-CN | Chinese (China) | CYP4F2 基因.c.1297G>A: Synonyms: A 型 C 型; |
79721-7 CYP4F2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Term Description
The CYP4F2 gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting CYP4F2 gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html]
Source: Regenstrief LOINC
Part Descriptions
LP202924-9 CYP4F2 gene product metabolic activity interpretation
Cytochrome P450-4F2 (CYP4F2; [HGNC Gene ID: 2645]), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism of a number of clinically relevant substrates in current clinical use. Genetic variations in CYP4F2 can affect the response (i.e., efficacy or toxicity) to drugs and other compounds metabolized by CYP4F2 and selection of alternative dosing or agents may be necessary in individuals with specific CYP4F2 genetic variations. See https://www.pharmgkb.org/gene/PA27121 for more information.
Source: Clinical Pharmacogenetics Implementation Consortium
Fully-Specified Name
- Component
- CYP4F2 gene product metabolic activity interpretation
- Property
- Imp
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Ord
- Method
- Molgen
Additional Names
- Short Name
- CYP4F2 gene prod met activ imp Bld/T-Imp
- Display Name
- CYP4F2 gene product metabolic activity interpretation Molgen Ql (Bld/Tiss) [Interp]
- Consumer Name Alpha Get Info
- CYP4F2 gene product metabolic activity interpretation, Blood or tissue specimen
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.54
- Last Updated
- Version 2.67
- Order vs. Observation
- Observation
Preferred Answer List LL3856-3
Answer | Code | Score | Answer ID |
---|---|---|---|
Ultrarapid metabolizer | LA10315-2 | ||
Rapid metabolizer | LA25390-8 | ||
Normal metabolizer | LA25391-6 | ||
Intermediate metabolizer | LA10317-8 | ||
Poor metabolizer | LA9657-3 |
Member of these Panels
LOINC | Long Common Name |
---|---|
93196-4 | Warfarin response genotype panel - Blood or Tissue by Molecular genetics method |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen CYP4F2 interpretation de la actividad en el metabolismo de fármacos: |
es-MX | Spanish (Mexico) | Interpretación de la actividad metabólica del producto del gen CYP4F2: |
fr-FR | French (France) | CYP4F2 gène activité métabolique interprétation: |
it-IT | Italian (Italy) | Interpretazione dell'attività metabolica del gene CYP4F2: Synonyms: Farmacogenomica Genetica molecolare Impressione/interpretazione di studio Interpretazione dell''attività metabolica del gene Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
nl-NL | Dutch (Netherlands) | CYP4F2-gen product metabole activiteit interpretatie: Synonyms: CYP4F2 gen product metabole activiteit interpretatie molgen |
tr-TR | Turkish (Turkey) | CYP4F2 geni ürünü metabolik aktivite yorumu: |
zh-CN | Chinese (China) | CYP4F2 基因产物新陈代谢活性解释: Synonyms: CYP4F2 基因产物新陈代谢(代谢)活性解释(说明、 |